← All stories
Health, Longevity & Biohacking

Bodybuilder Argues Most Americans Would Benefit from Tirzepatide Regardless of Weight Status

The Checkup with Doctor Mike · He Takes Steroids, Got Plastic Surgery & Says Vanity Can Make You Healthier · July 5, 2026
Bodybuilder Argues Most Americans Would Benefit from Tirzepatide Regardless of Weight Status
The Checkup with Doctor Mike
The Checkup with Doctor Mike
He Takes Steroids, Got Plastic Surgery & Says Vanity Can Make You Healthier
"I would venture to claim that almost all American adults at some dose of tirzepatide would be better off than not. Period."
Dr. Israetel claims that nearly all American adults would benefit from GLP-1 medications like tirzepatide, even those not overweight or diabetic, due to non-weight-mediated benefits like reduced inflammation, improved cardiac outcomes, and cancer prevention. He characterizes it as a revolutionary "phase three" drug where benefits vastly outweigh risks for the general population.

About this episode

Dr. Mike Varshavski hosts Dr. Mike Israetel, a bodybuilder, exercise scientist, and author of "The Aesthetic Revolution," for a wide-ranging debate on healthcare regulation, AI, vanity, and the future of medicine. Israetel makes several provocative claims that challenge medical and regulatory consensus. He argues the FDA drug approval process "murders people" by delaying access to potentially life-saving treatments, proposing instead that all drugs—including experimental ones—should be sold over the counter with simple warning labels. He predicts AI will create billions of genius-level researchers by 2028, enabling age reversal and genetic perfection for nearly everyone by 2039. On public health, Israetel contends vanity motivates people 10 times more effectively than health messaging, and that nearly all American adults would benefit from GLP-1 drugs like tirzepatide regardless of weight status. He advocates eliminating internet anonymity through mandatory "deep ID" verification to protect teenagers and prevent foreign manipulation. Throughout the episode, Dr. Varshavski challenges these claims from a clinical medicine perspective, questioning the practicality, safety implications, and evidence base. The conversation reveals fundamental disagreements about regulatory philosophy, with Israetel favoring radical libertarian approaches to drug access and Varshavski defending existing safety frameworks. Multiple fact-checks appear throughout correcting both participants. The discussion spans pharmaceutical regulation, AI predictions, social media harms, body image psychology, and the tension between individual liberty and public health protection.

Key takeaways

More stories More from The Checkup with Doctor Mike